Hepatitis B virus-related hepatocellular carcinoma: primary, secondary, and tertiary prevention

  title={Hepatitis B virus-related hepatocellular carcinoma: primary, secondary, and tertiary prevention},
  author={A. Giacomin and N. Cazzagon and A. Sergio and Veronica Vanin and F. Farinati},
  journal={European Journal of Cancer Prevention},
  • A. Giacomin, N. Cazzagon, +2 authors F. Farinati
  • Published 2011
  • Medicine
  • European Journal of Cancer Prevention
  • With respect to hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), primary, secondary, and tertiary prevention measures have been or should be adopted. In primary prevention, behavioral patterns represent an important risk factor for HBV infection and should be controlled, discouraging those favoring infection. Interferon treatment shows a modest effect in reducing HCC risk in treated patients, but the data obtained cannot be converted in clinical practice. Nucleoside analogs… CONTINUE READING
    10 Citations
    Development and novel therapeutics in hepatocellular carcinoma: a review
    • 26
    • PDF
    Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview
    • 6
    Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis B.
    • J. Kittner, M. Sprinzl, +4 authors M. Schuchmann
    • Medicine
    • Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
    • 2012
    • 46
    Prioritizing strategies for comprehensive liver cancer control in Asia: a conjoint analysis
    • 13
    • PDF
    Cancer control and prevention in Europe: the contribution of the European Journal of Cancer Prevention.
    • J. P. Janssens, C. la Vecchia
    • Medicine
    • European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation
    • 2012


    Prevention of hepatitis B virus-related hepatocellular carcinoma.
    • A. Lok
    • Medicine
    • Gastroenterology
    • 2004
    • 134
    Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach.
    • 342
    Patterns of hepatocellular carcinoma development in hepatitis B virus and hepatitis C virus related cirrhosis.
    • 48
    Epidemiology, risk factors and surveillance of hepatocellular carcinoma.
    • 84
    • PDF
    Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma.
    • 282
    • Highly Influential
    Prevention of hepatocellular carcinoma in the Asia–Pacific region: Consensus statements
    • 131
    The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma
    • 88
    • PDF